AstraZeneca's (AZN.UK) shares fell as much as 9.2% and touched their lowest level since April. However buyers managed to halt declines at 74.22 level and price bounced off. Currently stock is testing resistance at 77.67 which previously acted as a support. If buyers manage to break above it, an upward impulse towards major resistance at 82.20 could be launched. This level is additionally strengthened by 50 SMA (green line) and 200 SMA (red line). On the other hand, failure to break higher could see the stock pull back towards aforementioned support at 74.22 area. Source: xStation5Market Wrap: Rebound in China and Falling Oil Prices, France Leads EU Declines
Chart of the Day: What’s next for tech stocks after the deepest sell-off since April 2025? (19.10.2026)
Economic Calendar: Big tech earnings week and test for the AI rally (19.10.2026)
Morning Wrap: Nasdaq rebounds ahead of Mag7 earnings, bonds regain favour, oil falls from peak (19.10.2026)
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.